Effect of Interactive Tailored Assessment on Patient-provider Communication

NCT00857103 | Completed

• 1 other identifier: RCN 177500/V50
• Study Type: interventional
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

This interdisciplinary international research collaboration will test effects of Choice, a computer-assisted, interactive support system designed to help cancer patients communicate their symptoms and preferences, and clinicians in incorporating this information into patient care. In this pretest-post test clinical trial with 200 leukemia and lymphoma patients we will: 1) Test effects of Choice when integrated into routine clinical practice on: patient-provider communication, documented patient care, anxiety and patient satisfaction; 2) analyze relationships among the above variables and explore differences in these relationships between groups; 3) analyze group differences in communication style in terms of instrumental and affective behavior, content, participation, initiative and person addressed; and 4) investigate the extent of the time requirements when using Choice in clinical practice, perceived usefulness and ease of use.

Conditions

Lymphoma

Keywords

computer support; patient-provider communication; patient-centered care; cancer

Outcome Measures

Primary Outcomes (3)

• Patient satisfaction

  one point assessment

• Anxiety

  one point assessment

• communication

  one point assessment

Study Arms (2)

1

NO INTERVENTION

Standard care

2

EXPERIMENTAL

Use of Choice intervention to support consultations

Behavioral: CHOICE

Interventions

CHOICE BEHAVIORAL

Use of Choice support system as preparation for patient consultations

Also known as: Standard care

2

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosed with leukemia or lymphoma and in treatment or follow up after treatment within last 12 months.
• Being able to understand, speak and write Norwegian.
• Informed consent

You may not qualify if:

• If clinician know patient will receive bad news regarding outcome.

Sponsors & Collaborators

• Oslo University Hospital: lead
• The Research Council of Norway: collaborator

Study Sites (1)

Rikshospitalet University Hospital

Oslo, Oslo County, 0027, Norway

Location

Related Publications (1)

• Heyn L, Ruland CM, Finset A. Effects of an interactive tailored patient assessment tool on eliciting and responding to cancer patients' cues and concerns in clinical consultations with physicians and nurses. Patient Educ Couns. 2012 Feb;86(2):158-65. doi: 10.1016/j.pec.2011.04.024. Epub 2011 May 17.

  PMID: 21592719 DERIVED

MeSH Terms

Conditions

Lymphoma; Neoplasms

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Neoplasms by Histologic Type; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health Care; Quality of Health Care; Health Services Administration; Health Care Quality, Access, and Evaluation

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 5, 2009
• First Posted: March 6, 2009
• Study Start: August 1, 2006
• Primary Completion: June 1, 2009
• Study Completion: June 1, 2009
• Last Updated: June 17, 2013

Record last verified: 2013-06

Locations

NO (1)